£52.78

Advances in the Treatment of Kidney and Upper Urinary Tract Cancers

Price data last checked 22 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£53 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 69 days · 69 data points (no recent data)

Historical
Generating forecast…
£52.78 £50.14 £51.20 £52.25 £53.31 £54.36 £55.42 09 July 2026 26 July 2026 12 August 2026 29 August 2026 15 September 2026

Price Distribution

Price distribution over 69 days • 1 price levels

Days at Price
69 days 0 17 35 52 69 £53 Days at Price

Price Analysis

Most common price: £53 (69 days, 100.0%)

Price range: £53 - £53

Price levels: 1 different prices over 69 days

Description

Kidney and Upper Tract Urinary Cancers (UTUCs) are diseases of increasing population coverage, the treatment of which is undergoing a continuous process of evolution. A characteristic feature of renal cell cancer (RCC) treatment is the significant heterogeneity of patients (including different stages of local advancement and different locations of metastases). Importantly, it is estimated that up to 30% of newly diagnosed RCC cases are patients with disseminated disease at the time of diagnosis. Therefore, predicting the response to modern treatment remains the unmet need of modern urologic oncology. Recent advancements in systematic treatment, i.e., immunotherapy, shed additional light on adjuvant treatment to be implemented in new clinical scenarios, including localized disease.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
12 March 2024
Listed Since
13 March 2024

Barcode

No barcode data available

Similar Products You Might Like

Advances in the Treatment of Renal Cell Carcinoma
86% match

Advances in the Treatment of Renal Cell Carcinoma

£41.90 14 Sep 2026
Advancements in Lung Cancer Surgical Treatment and Prognosis
83% match

Advancements in Lung Cancer Surgical Treatment and Prognosis

£62.50 23 Aug 2026
Novel Therapeutic Approaches for Cancer Treatment
82% match

Novel Therapeutic Approaches for Cancer Treatment

£95.56 22 Aug 2026
Immunotherapy in Hepatocellular Carcinoma
82% match

Immunotherapy in Hepatocellular Carcinoma

£64.26 22 Aug 2026
Contemporary Research on Renal Cell Carcinoma: Basic and Clinical Developments
82% match

Contemporary Research on Renal Cell Carcinoma: Basic and Clinical Developments

Springer

£76.42 15 Sep 2026
Management of Pancreatic Cancer
82% match

Management of Pancreatic Cancer

£80.06 22 Aug 2026
Modern Approach to Diagnosis and Treatment of Bladder Cancer
82% match

Modern Approach to Diagnosis and Treatment of Bladder Cancer

IntechOpen

£114.00 29 Aug 2026
Upper Tract Urothelial Carcinoma
82% match

Upper Tract Urothelial Carcinoma

Springer

£88.21 08 Aug 2026
Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider
81% match

Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider

Springer

£90.42 03 Aug 2026
Advanced and Metastatic Renal Cell Carcinoma, An Issue of Urologic Clinics (Volume 47-3) (The Clinics: Surgery, Volume 47-3)
81% match

Advanced and Metastatic Renal Cell Carcinoma, An Issue of Urologic Clinics (Volume 47-3) (The Clinics: Surgery, Volume 47-3)

Elsevier

£69.11 13 Sep 2026
Endocrine and Neuroendocrine Cancers
81% match

Endocrine and Neuroendocrine Cancers

£51.92 23 Aug 2026
Advances in Plant-Sourced Natural Compounds as Anticancer Agents
81% match

Advances in Plant-Sourced Natural Compounds as Anticancer Agents

£54.17 22 Aug 2026
Advances in Cancer Therapy from Research to Clinical Practice: Surgical, Molecular or Systemic Management of Cancer
81% match

Advances in Cancer Therapy from Research to Clinical Practice: Surgical, Molecular or Systemic Management of Cancer

£64.26 14 Sep 2026
Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer
81% match

Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer

MDPI AG

£64.85 29 Aug 2026
Pediatric Cancers
80% match

Pediatric Cancers

£70.80 29 Jul 2026
New Insights into Endometrial Cancer 2022
80% match

New Insights into Endometrial Cancer 2022

£51.92 23 Aug 2026
Quality of Life and Side Effects Management in Cancer Treatment
80% match

Quality of Life and Side Effects Management in Cancer Treatment

£52.78 23 Aug 2026
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
80% match

Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression

£82.80 22 Aug 2026
Prostate Cancer: Symptoms, Diagnosis & Treatment
80% match

Prostate Cancer: Symptoms, Diagnosis & Treatment

£87.53 22 Aug 2026
Advances in Personalized Cancer Management
79% match

Advances in Personalized Cancer Management

£85.00 10 Aug 2026
Renal Cancer: Methods and Protocols: 53 (Methods in Molecular Medicine, 53)
79% match

Renal Cancer: Methods and Protocols: 53 (Methods in Molecular Medicine, 53)

Humana

£103.27 07 Aug 2026
Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning
79% match

Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning

£47.59 14 Sep 2026
Bladder Cancer - Management of NMI and Muscle-Invasive Cancer
79% match

Bladder Cancer - Management of NMI and Muscle-Invasive Cancer

IntechOpen

£101.15 29 Jul 2026
Emerging Antibody Engineering Strategies and Applications for Immunotherapy of Cancer
79% match

Emerging Antibody Engineering Strategies and Applications for Immunotherapy of Cancer

£62.50 18 Aug 2026